Bristol-Myers Squibb Award Goes to Folkman
NEW YORK--Judah Folkman, MD, who first theorized that tumors form and metastasize by means of angiogenesis, is the winner of the 18th annual Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research.
NEW YORK--Judah Folkman, MD, who first theorized that tumors formand metastasize by means of angiogenesis, is the winner of the18th annual Bristol-Myers Squibb Award for Distinguished Achievementin Cancer Research.
In 1971, Dr. Folkman reported the isolation of the first angiogenicfactor, a substance that induces blood vessel growth. In 1984,he and his colleagues Yuen Shing and Michael Klagsbrun purifiedthe first tumor-derived angiogenic factor, and Dr. Folkman laterdiscovered the first angiogenesis inhibitor.
Dr. Folkman is Julia Dyckman Andrus Professor of Pediatric Surgery,Harvard Medical School, and director of the Surgical ResearchLaboratory, Children's Hospital, Boston.
The company also announced the recipients of the 1995 Bristol-MyersSquibb Unrestricted Cancer Research Grants--Indiana UniversityCancer Center and the National Cancer Institute, Milan.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Similar Splenic, Symptom Responses Are Reported With Ruxolitinib Combos in Myelofibrosis With Anemia
June 13th 2025Results of a post hoc analysis found spleen and symptom response rates to be comparable with ESAs or danazol in combination with ruxolitinib for patients with myelofibrosis who have anemia.
